Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

The European Medicines Agency has announced that its new and improved version of EudraVigilance, the European information system of suspected adverse reactions to medicines, is on track to go live on 22 November 2017

The EMA’s Pharmacovigilance Risk Assessment Committee has audited the new EudraVigilance information system for tracking suspected adverse reactions to authorised drugs and medicines being studied in clinical trials across the European Economic Area